Little change in survival rates despite cancer spending plan
Cash injection has failed to have impact, study showsThe government's national cancer plan, backed by a massive injection of cash for cancer services in England, has failed to boost survival rates substantially, a major study shows today.The findings will dismay government ministers, who have secured a tripling of spending on cancer over the last decade with the ambition of bringing the UK from among the worst countries up to the standard of the best in Europe. But the authoritative study, from a team led by Professor Michel Coleman at the London School of Hygiene and Tropical Medicine, shows that survival rates have barely shifted since the cancer plan was launched in 2000."We are at best keeping track with improvements elsewhere rather than closing the gap," says an editorial in the journal which publishes today's study, Lancet Oncology. It adds that the government's aim of matching the survival rates of the...
Read the whole article on The Guardian - Science
More from The Guardian - Science
Related
- Analysis of cancer incidence, mortality and survival combined reveals encouraging European trendsWed, 2 Jul 2008, 5:35:49 EDT
- New data on cancer survival in Europe show more patients are curedTue, 24 Mar 2009, 7:44:38 EDT
- New therapeutic treatment approach improves survival in esophageal cancer patientsMon, 6 Oct 2008, 11:29:14 EDT
- New analysis shows liver cancer incidence has tripled since 1970s, but survival rates improvingWed, 18 Feb 2009, 15:15:12 EST
- Surgery improves survival for prostate cancer patients younger than 50Mon, 11 May 2009, 10:51:58 EDT